A top U.S. official suggested Wednesday that people who received the Johnson & Johnson vaccine likely are protected against the delta variant.
U.S. Surgeon General Dr. Vivek Murthy told CNBC that data shows the Oxford-AstraZeneca shot — a “cousin” of the J&J — is highly effective against the variant first identified in India and currently surging across the nation.
“While we are still awaiting direct studies of Johnson & Johnson and the delta variant, we have reasons to be hopeful, because the J&J vaccine has proven to be quite effective against preventing hospitalizations and deaths, with all the variants that we’ve seen to date,” Murthy said.
Murthy’s comments come as other companies like Moderna announced that their
